VDR and neoplasm: We would argue that the effect of defective tumour VDR signalling could result in loss of suppression of growth, reduction of anti‐tumour immunity, with potential antagonism of the elimination phase and enhancement of the escape phase of tumour immunoediting, possibly increased angiogenesis but continued suppression of inflammation.